VOICED : Vacuna de Pfizer funciona frente a variante india pero es "ligeramente” menos eficaz (estudio)

The video discusses a study from the Pasteur Institute in Paris, which found that the Pfizer-BioNTech vaccine produces antibodies capable of neutralizing the coronavirus variant discovered in India, though with slightly reduced efficacy. It also highlights that the vaccine is effective against the UK variant. The study further examines the AstraZeneca vaccine, noting that a single dose is effective against the UK variant but less so against the Indian and South African variants. The AstraZeneca vaccine was introduced in the EU in February, with a recommended 12-week interval between doses.

What is the efficacy of the Pfizer-BioNTech vaccine against the Indian variant of the coronavirus?

• Highly effective

• More effective than against the English variant

• Not effective at all

• Slightly less effective

According to the study, how do the antibodies from the Pfizer-BioNTech vaccine perform against the English variant?

• They are more effective than against the South African variant

• They are effective

• They are equally effective as against the Indian variant

• They are ineffective

What was a limitation in the study of the AstraZeneca vaccine's efficacy?

• The study was conducted outside Europe

• Both doses were tested

• Only one dose was tested

• The study included all variants

How effective is one dose of the AstraZeneca vaccine against the English variant?

• Not effective

• Slightly effective

• Highly effective

• Moderately effective

What is the recommended waiting period between doses of the AstraZeneca vaccine in the EU?

• 4 weeks

• 16 weeks

• 8 weeks

• 12 weeks